Chuqi Wang

708 total citations · 1 hit paper
13 papers, 506 citations indexed

About

Chuqi Wang is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Chuqi Wang has authored 13 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Chuqi Wang's work include CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (3 papers) and Acute Myeloid Leukemia Research (2 papers). Chuqi Wang is often cited by papers focused on CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (3 papers) and Acute Myeloid Leukemia Research (2 papers). Chuqi Wang collaborates with scholars based in China, Singapore and United States. Chuqi Wang's co-authors include Shi Hu, Changhai Lei, Wenyan Fu, Fangxing Lin, Yingshu Cui, Shuowu Liu, Min Ding, Li Tian, Kewen Qian and Yongji Yang and has published in prestigious journals such as Nature Communications, Leukemia and Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy.

In The Last Decade

Chuqi Wang

11 papers receiving 501 citations

Hit Papers

CAR exosomes derived from effector CAR-T cells have poten... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuqi Wang China 7 331 170 165 144 117 13 506
Fangxing Lin China 8 391 1.2× 179 1.1× 192 1.2× 181 1.3× 136 1.2× 10 600
Shuowu Liu China 6 397 1.2× 185 1.1× 222 1.3× 137 1.0× 116 1.0× 8 550
Yingshu Cui China 5 322 1.0× 160 0.9× 164 1.0× 113 0.8× 115 1.0× 9 450
Sitian Wei China 12 302 0.9× 86 0.5× 208 1.3× 50 0.3× 78 0.7× 24 511
Jizhou Tan China 10 239 0.7× 189 1.1× 110 0.7× 259 1.8× 127 1.1× 17 625
Kesang Li China 13 428 1.3× 270 1.6× 274 1.7× 364 2.5× 83 0.7× 20 811
Taixian Yuan China 12 406 1.2× 38 0.2× 179 1.1× 77 0.5× 105 0.9× 20 514
Jonas R.M. Van Audenaerde Belgium 15 158 0.5× 273 1.6× 50 0.3× 365 2.5× 78 0.7× 24 722
Jia Song China 11 217 0.7× 132 0.8× 92 0.6× 80 0.6× 32 0.3× 19 398
Jinsong Wei China 10 142 0.4× 96 0.6× 40 0.2× 75 0.5× 72 0.6× 19 334

Countries citing papers authored by Chuqi Wang

Since Specialization
Citations

This map shows the geographic impact of Chuqi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuqi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuqi Wang more than expected).

Fields of papers citing papers by Chuqi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuqi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuqi Wang. The network helps show where Chuqi Wang may publish in the future.

Co-authorship network of co-authors of Chuqi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Chuqi Wang. A scholar is included among the top collaborators of Chuqi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuqi Wang. Chuqi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Chong, Stephen Jun Fei, Kartini Iskandar, Chuqi Wang, et al.. (2025). Superoxide-mediated phosphorylation and stabilization of Mcl-1 by AKT underlie venetoclax resistance in hematologic malignancies. Leukemia. 39(10). 2477–2491. 2 indexed citations
4.
Krishnan, Vaidehi, King Pan Ng, Chuqi Wang, et al.. (2024). The BIM deletion polymorphism potentiates the survival of leukemia stem and progenitor cells and impairs response to targeted therapies. Leukemia. 39(1). 134–143.
5.
Wang, Chuqi, et al.. (2024). TP53 Mutation-Mediated Immune Evasion in Cancer: Mechanisms and Therapeutic Implications. Cancers. 16(17). 3069–3069. 26 indexed citations
6.
Wang, Chuqi. (2023). A Review on 3D Convolutional Neural Network. 1204–1208. 8 indexed citations
7.
Fu, Wenyan, Changhai Lei, Chuqi Wang, et al.. (2022). Synthetic libraries of immune cells displaying a diverse repertoire of chimaeric antigen receptors as a potent cancer immunotherapy. Nature Biomedical Engineering. 6(7). 842–854. 12 indexed citations
8.
Yang, Shuo, et al.. (2022). A novel efficient red-emitting K7SrY2B15O30: Eu3+ phosphor with non-concentration quenching and robust thermal stability for white LEDs. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 287(Pt 2). 122126–122126. 16 indexed citations
9.
Wang, Chuqi & Ming Chu. (2022). Advances in Drugs Targeting Lymphangiogenesis for Preventing Tumor Progression and Metastasis. Frontiers in Oncology. 11. 783309–783309. 15 indexed citations
10.
Wang, Chuqi, Wenyan Fu, Changhai Lei, & Shi Hu. (2022). Generation and functional characterization of CAR exosomes. Methods in cell biology. 167. 123–131. 5 indexed citations
11.
Meng, Hao, et al.. (2022). Research on the Evaluation of Digital Village Development Readiness Taking Changfeng County as an Example. International Journal of Education and Humanities. 2(3). 155–159. 4 indexed citations
12.
Fu, Wenyan, Changhai Lei, Shuowu Liu, et al.. (2019). CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity. Nature Communications. 10(1). 4355–4355. 389 indexed citations breakdown →
13.
Liu, Shuowu, Chuqi Wang, Yingshu Cui, et al.. (2019). Treatment of murine lupus with TIGIT-Ig. Clinical Immunology. 203. 72–80. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026